These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8741040

  • 1. Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis.
    Lauterbach R, Zembala M.
    Eur J Pediatr; 1996 May; 155(5):404-9. PubMed ID: 8741040
    [Abstract] [Full Text] [Related]

  • 2. Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial.
    Lauterbach R, Pawlik D, Kowalczyk D, Ksycínski W, Helwich E, Zembala M.
    Crit Care Med; 1999 Apr; 27(4):807-14. PubMed ID: 10321674
    [Abstract] [Full Text] [Related]

  • 3. Effects of treatment with pentoxifylline on the cardiovascular manifestations of group B streptococcal sepsis in the piglet.
    Del Moral T, Goldberg RN, Urbon J, Suguihara C, Martinez O, Stein-Streilein J, Feuer WJ, Bancalari E.
    Pediatr Res; 1996 Sep; 40(3):469-74. PubMed ID: 8865286
    [Abstract] [Full Text] [Related]

  • 4. Pentoxifylline treatment of sepsis of premature infants: preliminary clinical observations.
    Lauterbach R, Pawlik D, Tomaszczyk B, Cholewa B.
    Eur J Pediatr; 1994 Sep; 153(9):672-4. PubMed ID: 7957428
    [Abstract] [Full Text] [Related]

  • 5. Effect of pentoxifylline on tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis.
    Selim K, Hüseyin C, Ibrahim KH, Hasan BU, Kazim U, Hüseyin K.
    Med J Malaysia; 2004 Aug; 59(3):391-4. PubMed ID: 15727386
    [Abstract] [Full Text] [Related]

  • 6. Effects of maturation and size on population pharmacokinetics of pentoxifylline and its metabolites in very preterm infants with suspected late-onset sepsis or necrotizing enterocolitis: a pilot study incorporating clinical outcomes.
    Salman S, Hibbert J, Page-Sharp M, Manning L, Simmer K, Doherty DA, Patole S, Batty KT, Strunk T.
    Br J Clin Pharmacol; 2019 Jan; 85(1):147-159. PubMed ID: 30281170
    [Abstract] [Full Text] [Related]

  • 7. The effects of aminophylline and pentoxifylline on multiple organ damage after Escherichia coli sepsis.
    Harada H, Ishizaka A, Yonemaru M, Mallick AA, Hatherill JR, Zheng H, Lilly CM, O'Hanley PT, Raffin TA.
    Am Rev Respir Dis; 1989 Oct; 140(4):974-80. PubMed ID: 2529804
    [Abstract] [Full Text] [Related]

  • 8. Intravenous pentoxifylline is well tolerated in critically ill preterm infants with sepsis or necrotizing enterocolitis.
    Schüller SS, Kempf K, Unterasinger L, Strunk T, Berger A.
    Eur J Pediatr; 2020 Aug; 179(8):1325-1330. PubMed ID: 32179980
    [Abstract] [Full Text] [Related]

  • 9. Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth weight infants: a pilot clinical study.
    Lauterbach R, Szymura-Oleksiak J, Pawlik D, Warchoł J, Lisowska-Miszczyk I, Rytlewski K.
    J Matern Fetal Neonatal Med; 2006 Jul; 19(7):433-8. PubMed ID: 16923699
    [Abstract] [Full Text] [Related]

  • 10. Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis.
    Romagnoli C, Frezza S, Cingolani A, De Luca A, Puopolo M, De Carolis MP, Vento G, Antinori A, Tortorolo G.
    Eur J Pediatr; 2001 Jun; 160(6):345-50. PubMed ID: 11421413
    [Abstract] [Full Text] [Related]

  • 11. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study.
    Zeni F, Pain P, Vindimian M, Gay JP, Gery P, Bertrand M, Page Y, Page D, Vermesch R, Bertrand JC.
    Crit Care Med; 1996 Feb; 24(2):207-14. PubMed ID: 8605790
    [Abstract] [Full Text] [Related]

  • 12. Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study.
    Staubach KH, Schröder J, Stüber F, Gehrke K, Traumann E, Zabel P.
    Arch Surg; 1998 Jan; 133(1):94-100. PubMed ID: 9438767
    [Abstract] [Full Text] [Related]

  • 13. Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates.
    Haque KN, Pammi M.
    Cochrane Database Syst Rev; 2011 Oct 05; (10):CD004205. PubMed ID: 21975745
    [Abstract] [Full Text] [Related]

  • 14. Pentoxifylline improves circulatory and metabolic recovery after cardiopulmonary resuscitation.
    Bahlmann L, Pagel H, Klaus S, Heringlake M, Schmucker P, Wagner K.
    Resuscitation; 2000 Oct 05; 47(2):191-4. PubMed ID: 11008158
    [Abstract] [Full Text] [Related]

  • 15. Association between high cytokine levels with white matter injury in preterm infants with sepsis.
    Procianoy RS, Silveira RC.
    Pediatr Crit Care Med; 2012 Mar 05; 13(2):183-7. PubMed ID: 21666535
    [Abstract] [Full Text] [Related]

  • 16. Pentoxifylline therapy for late-onset sepsis in preterm infants: a randomized controlled trial.
    Shabaan AE, Nasef N, Shouman B, Nour I, Mesbah A, Abdel-Hady H.
    Pediatr Infect Dis J; 2015 Jun 05; 34(6):e143-8. PubMed ID: 25970116
    [Abstract] [Full Text] [Related]

  • 17. Effects of pentoxifylline on the cardiovascular manifestations of group B streptococcal sepsis in the piglet.
    Del Moral T, Goldberg RN, Suguihara C, Martinez O, Feuer WJ, Bancalari E.
    Pediatr Res; 1992 Jun 05; 31(6):596-600. PubMed ID: 1635822
    [Abstract] [Full Text] [Related]

  • 18. Pentoxifylline inhibits interleukin-2-induced toxicity in C57BL/6 mice but preserves antitumor efficacy.
    Edwards MJ, Heniford BT, Klar EA, Doak KW, Miller FN.
    J Clin Invest; 1992 Aug 05; 90(2):637-41. PubMed ID: 1644928
    [Abstract] [Full Text] [Related]

  • 19. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis.
    Harris MC, Costarino AT, Sullivan JS, Dulkerian S, McCawley L, Corcoran L, Butler S, Kilpatrick L.
    J Pediatr; 1994 Jan 05; 124(1):105-11. PubMed ID: 8283358
    [Abstract] [Full Text] [Related]

  • 20. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy.
    Sliwa K, Skudicky D, Candy G, Wisenbaugh T, Sareli P.
    Lancet; 1998 Apr 11; 351(9109):1091-3. PubMed ID: 9660578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.